Global Oncology Clinical Trials Market Size to Exceed USD 23.56 Billion by 2035 | CAGR Of 5.23%
Category: HealthcareGlobal Oncology Clinical Trials Market Size to Exceed USD 23.56 Billion by 2035
According to a research report published by Spherical Insights & Consulting, the Global Oncology Clinical Trials Market Size is Expected to Grow from USD 13.45 Billion in 2024 to USD 23.56 Billion by 2035, at a CAGR of 5.23% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 225 pages with 119 Market data tables and figures & charts from the report on the "Global Oncology Clinical Trials Market Size, Share, and COVID-19 Impact Analysis, By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Interventional Studies, Observational Studies, and Expanded Access Studies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035". Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/oncology-clinical-trials-market
The oncology clinical trials market is a global industry devoted to conducting regulated clinical research to evaluate the efficacy, safety, and outcomes of novel cancer treatments. Including studies in all phases (I–IV) with both interventional and observational designs, it targets several cancer types, including leukemia, breast, and lung cancer. Technological integration and shifting regulatory frameworks influence the market and encourage innovation in cell-based therapies, immunotherapy, and targeted therapy. Its growth reflects the growing demand for effective, customized oncology solutions globally. The growing global incidence of cancer is driving the market for oncology clinical trials, pushing pharmaceutical corporations, and significantly increasing demand. Patient-centric trial designs, which put the patient experience first and have significant opportunities for efficiency and innovation, are revolutionizing the oncology clinical trial market. An increase in the incidence of cancer is driving the market for oncology clinical trials and increasing the need for a range of customized treatment options. However, complicated procedures, high operating expenses, difficult patient recruiting, strict laws, and restricted access to a variety of groups all restrict oncology clinical trials market expansion.
The phase I segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the phase type, the oncology clinical trials market is divided into phase I, phase II, phase III, and phase IV. Among these, the phase I segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. An increasing focus on biomarker-driven strategies, personalized medicine, and the investigation of novel drug combinations are trends in Phase I oncology trials.
The interventional studies segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the study design, the oncology clinical trials market is divided into interventional studies, observational studies, and expanded access studies. Among these, the interventional studies segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Interventional studies actively investigate how particular medicines affect the course of cancer in the field of oncology clinical trials.
North America is expected to hold the majority share of the global oncology clinical trials market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global oncology clinical trials market during the forecast period. The presence of significant market participants and a number of advantageous reimbursement rules in North America encourages investment and the creation of new products. North America is a significant center for oncology clinical research and commercial leadership because of its centralized setting and highly qualified personnel, which enable effective trial execution.
Asia Pacific is anticipated to grow at the fastest pace in the global oncology clinical trials market during the forecast period. The Asia-Pacific market for cancer research is growing significantly as a result of these elements coming together. The regional market is further supported by the large patient pool and low cost of conducting clinical trials in the area, as well as the availability of a sizable number of Food and Drug Administration (FDA) personnel.
Major vendors in the global oncology clinical trials market are AbbVie Inc., Sanofi, Pivotal, IQVIA Inc., Medpace, Novotech, Astrazeneca, Merck & Co., Inc., Syneos Health, PRA Health Sciences, Gilead Sciences, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, PAREXEL International Corporation, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2025, the second patient was dosed in the Phase 2 clinical trial protocol, which was carried out to assess the effectiveness of stenoparib, a differentiated inhibitor of the PARP and WNT pathways, in patients with advanced, recurrent, platinum-ineligible, or platinum-resistant ovarian cancer. A Phase 2 clinical-stage pharmaceutical business called Allarity Therapeutics, Inc., manufactured the stenoparib.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the oncology clinical trials market based on the below-mentioned segments:
Global Oncology Clinical Trials Market, By Phase Type
- Phase I
- Phase II
- Phase III
- Phase IV
Global Oncology Clinical Trials Market, By Study Design
- Interventional Studies
- Observational Studies
- Expanded Access Studies
Global Oncology Clinical Trials Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?